Patents Assigned to Callisto Pharmaceuticals, Inc.
  • INTERMITTENT DOSING STRATEGY FOR TREATING RHEUMATOID ARTHRITIS
    Publication number: 20100203146
    Abstract: The present invention provides methods of treating rheumatoid arthritis. The methods generally involve an intermittent dosing strategy for administering Atiprimod alone or in combination with a second therapeutic agent wherein the second therapeutic agent is selected from the group consisting of Methotrexate, gold compounds, antimalarials, cyclosporine A, leflunomide, azathioprine, sulfasalazine d-penicillamine, aurothioglucose, auranofin, or a TNF inhibitor.
    Type: Application
    Filed: February 9, 2010
    Publication date: August 12, 2010
    Applicant: Callisto Pharmaceuticals, Inc.
    Inventor: Gary S. Jacob